Practical aspects of using beta-adrenergic blockade in systolic heart failure

American Journal of Medicine

Volumn 110, Issue 7, 2001, Pages 68-73

  Gheorghiade, Mihai ^a   Eichhorn, Eric J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL;

BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; HEART FAILURE; HUMAN; MAINTENANCE THERAPY; MEDICAL PRACTICE; PATIENT EDUCATION; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW;

EID: 0035821326     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(00)00575-1     Document Type: Review

References (39)

1. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
2. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
4. Survival after the onset of congestive heart failure in Framingham Heart Study subjects
5. The effect of digoxin on mortality and morbidity in patients with heart failure
6. The effect of diltiazem on mortality and reinfarction after myocardial infarction
7. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure
8. Effect of oral milrinone on mortality in severe chronic heart failure
9. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure
10. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
11. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
12. Clinical effects of β-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled, randomized trials
13. Effect of carvedilol on morbidity and mortality in chronic heart failure
14. The Cardiac Insufficiency Bisoprolol Study-II (CIBIS II). A randomized trial
15. Guidelines for the evaluation and management of heart failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)
16. Consensus recommendations for the management of chronic heart failure
17. Importance of adrenergic nervous system in the support of circulatory function in patients with congestive heart failure
18. Medical therapy can improve the biologic properties of the chronically failing heart: A new era in the treatment of heart failure
19. Effect of metoprolol on myocardial function and energetics in patients with non-ischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
20. Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure
21. Effect of carvedilol on LV function and mortality in diabetic versus non-diabetic patients with ischemic or nonischemic dilated cardiomyopathy
22. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: The carvedilol-metoprolol study
23. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension: A randomized, controlled trial
24. Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade
25. Beta-blocker Evaluation of Survival Trial (BEST)
26. Comparative effects of low and high doses of the antiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
27. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
28. A randomized trial of β-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS)
29. Should worsening heart failure early after initiation of beta-blocker therapy for chronic heart failure preclude long-term treatment?
30. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
31. Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy
32. Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes
33. Beta-blocker withdrawal: The song of Orpheus
34. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart
35. Differential effects of beta-blockers in patients with heart failure. A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol
36. Carvedilol improves renal hemodynamics in patients with chronic heart failure